Early development of CDX-1401, a novel vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205, in combination with toll-like receptor (TLR) agonists Meeting Abstract


Authors: Dhodapkar, M. V.; Sznol, M.; Wang, D.; Chuang, E.; Carvajal, R.; Kluger, H.; Ramakrishna, V.; Vitale, L.; Davis, T.; Steinman, R. M.; Keler, T.
Abstract Title: Early development of CDX-1401, a novel vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205, in combination with toll-like receptor (TLR) agonists
Meeting Title: 25th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer
Journal Title: Journal of Immunotherapy
Volume: 33
Issue: 8
Meeting Dates: 2010 Oct 2-4
Meeting Location: Washington, DC
ISSN: 1524-9557
Publisher: Lippincott Williams & Wilkins  
Date Published: 2010-10-01
Start Page: 895
End Page: 896
Language: English
ACCESSION: ISI:000282131800127
PROVIDER: wos
DOI: 10.1097/CJI.0b013e3181f1e08d
Notes: --- - Meeting Abstract - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Richard D Carvajal
    148 Carvajal